期刊文献+

PAX2在子宫内膜癌中的表达及其与ERα的相关性 被引量:4

下载PDF
导出
摘要 目的:探讨PAX2在子宫内膜癌组织中的表达情况,分析PAX2和子宫内膜癌临床病理参数的关系及其与ERα的相关性。方法:采用免疫组化法检测60例子宫内膜癌、20例子宫内膜不典型增生及30例正常子宫内膜组织中PAX2与ERα的表达情况。结果:(1)PAX2在正常子宫内膜组织、子宫内膜不典型增生、子宫内膜癌3组中的阳性表达率比较差异均有显著性(P<0.05)。PAX2的高表达与子宫内膜癌的病理类型、手术病理分期、肌层浸润深度及淋巴结转移有明显关系,与组织分化程度无明显相关(P>0.05)。(2)在ERα阳性的子宫内膜癌患者中,PAX2阳性表达率为75%,而在ERα阴性的子宫内膜癌患者中,PAX2阳性表达率为50%,两者相比有统计学意义(P<0.05)。结论:PAX2可作为判断子宫内膜癌预后的一种新指标,在子宫内膜癌中PAX2的表达可能与ERα密切相关。
出处 《实用医学杂志》 CAS 北大核心 2011年第2期186-188,共3页 The Journal of Practical Medicine
  • 相关文献

参考文献11

  • 1徐敬,吴中明.雌激素与子宫内膜癌相关性的研究进展[J].肿瘤防治研究,2004,31(7):448-450. 被引量:14
  • 2Shang Y F. Molecular mechanisms of oestrogen and SEMS in endometrial carcinoma [J]. Nature Reviews Cancer, 2006,6 (5) : 360-368.
  • 3朱清毅,顾晓箭,钱立新,吴宏飞.PAX2、PCNA以及nm23在肾细胞癌中的表达及意义[J].中国临床医学,2005,12(3):517-519. 被引量:2
  • 4徐艳红,温宏武.雌激素受体亚型ERα和ERβ在子宫内膜癌中表达的研究[J].中国医刊,2006,41(8):31-33. 被引量:10
  • 5Wu H, Chen Y, Liang J, et al. Hypomethylation-linked activation of pax2 mediates tamoxifen-stimulated endometrial carcinogenesis[J].Nature, 2005,438 ( 15 ) : 981-987.
  • 6Favor J, Sandulache R, Neuhauser-Klaus A, et al. The mouse pax2(1Neu) mutation is identical to a human pax2 in a trustily with renal-coloboma syndrome and results in developmental defects of the brain, ear, eye and kidney[J]. Proc Natl Acad Sci U S A, 1996, 93(24):13870-13875.
  • 7Park D, Jia H, Rajakumar V, et al. PAX2/5/8 proteins promote cell survival in C.elegants [Ji. Dvelopment, 2006, 133(21 ) : 4193-4420.
  • 8Muratovska A, Zhou C, He S, et al. Paired-box genes are frequently' expressed in caneer and often required for cancer cell survival [ J ]. Oneogene, 2003,22 (39) : 7989-7997.
  • 9Tong G X, Chiriboga L, Hamele-Bena D, et al. Expression of pax2 in papilla15' serous carcinoma of the oval" : immunohistochemical evidence of fallopian tube or secondary" Mullerian system origin? [J]. Mod Pathol, 2007.20(8) :856- 863.
  • 10姜艳超,丁丽华,杨群辉,胡建民,曾敏,杨智洪,王晓辉,李熔,叶棋浓.pax2启动子的克隆及其在人胚胎肾293T细胞中的转录活性[J].生物技术通讯,2007,18(4):561-563. 被引量:1

二级参考文献35

  • 1王殊,王杉,张嘉庆,乔新民,杨德启,佟富中,叶颖江,崔志荣.雌激素受体亚型在人乳腺癌的表达及意义[J].中华外科杂志,2004,42(13):792-794. 被引量:16
  • 2张家文,彭芝兰.雌激素受体亚型与子宫内膜癌预后因素的关系[J].四川大学学报(医学版),2004,35(6):843-845. 被引量:6
  • 3郭彩霞,魏丽惠,富琪,虞有智,虞幸.nm23-H1基因与子宫内膜癌的关系[J].北京医科大学学报,1997,29(2):126-128. 被引量:2
  • 4Sherman ME. Theories of endometrial carcinogenesis: a multidisciplinary approach[J].Mod Pathol,2000,13(3):295-308.
  • 5Kaku T,Tsukamoto N,Tooru T,et al. Endometrial carcinoma associated with hyperplasia[J].Gynecol Oncol, 1996,60(1):22-25.
  • 6Berstein LM, Bakhidze EV, Evtushenko TP,et al. Estrogen content and DNA unwinding in tumor and normal endometrial tissue of aging endometrial cancer patients[J].Mutat Res, 1996,356(2):203-208.
  • 7Hachisuga T, Miyakawa T, Tsujioka H,et al. K-ras mutation in tamoxifen-related endometrial polyps[J]. Cancer, 2003,98(9):1890-1897.
  • 8Bae-Jump H,Segreti EM.Vandermolen D,et al.Hepatocyte growth factor induces invasion of endometrial carcinoma cell lines in vitro[J]. Gynecol Oncol,1999,73(2):265.
  • 9Niwa K, Imai A, Hashimoto M,et al. A case-control study of uterine endometrial cancer of pre- and post-menopausal women[J]. Oncol Rep, 2000 ,7(1):89-93.
  • 10Beresford SA, Weiss NS, Voigt LF,et al. Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women[J]. Lancet, 1997,349(9050):458-461.

共引文献23

同被引文献25

  • 1Wu H, Chen Y, Liang J, et al. Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis[J] Nature,2005,438(7070):981-7.
  • 2Patricio P, Ramalho-Carvalho J, Costa-Pinheiro, et al. Deregulation of PAX2 expression in renal cell tumours: mechanisms and potential use in differential diaguosis[J]. J Cell Mol Med, 2013,17(8 ):1048- 58.
  • 3Bose SK, Gibson W, Girl, et al. Angiotensin Ii up-regulates PAX2 oncogene expression and activity in prostate cancer via the angiotensin II type I receptor[J]. Prostate, 2009,69( 12):1334-42.
  • 4Beauchemin D, Lacombe C, Van Themsch. PAX2 is activated by estradiol in breast cancer ceils of the luminal subgroup selectively, to confer a low invasive phenotype[ J ]. Mol Cancer, 2011,10:148.
  • 5Tung CS, Mok SC, Tsang Yt, et al. PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas [ J ]. Mod Pathol,2009,22(9 ): 1243-50.
  • 6Zhang SL, Chen Yw, Tran S, et al. Pax-2 and N-myc regulate epithelial cell proliferation and apoptosis in a positive autocrlne feedback loop[J]. Pediatr Nephrol, 2007, 22(6):813-824.
  • 7Shang Y. Molecular mechanisms of oestrogen and SERMs in endometrlal carcinogenesis[ J ]. Nat Rev Cancer, 2006,6( 5 ):360-368.
  • 8Tfimble C L, Kauderer J, Zaino R, et al. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Ontology Group study [J]. Cancer, 2006,106(4):812-9.
  • 9Quick CM, Laury Ar, G L Monte Nm, et al. Utility of PAX2 as a marker for diagnosis of endometrial intraepithelial neoplasia[J]. AmJ Clin Pathol, 2012,138(5):678-84.
  • 10Joiner AK, Quick Cm, SK Jeffus. Pax2 Expression in Simultaneously Diagnosed WHO and EIN Classification Systems [J]. Int J Gynecol Pathol,2015,34 ( 1 ) :40-6.

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部